A
Anbio Biotechnology Class A Ordinary Shares
Q3 2026 earnings expected
Quarter
Jul – Sep
Expected
November 14, 2026(ET)
Revenue Growth Trajectory
+87%YoY
Last 7 quarters
Anbio Biotechnology Class A Ordinary Shares
Jul – Sep
November 14, 2026(ET)
Last 7 quarters